August 20th, 2025 WRITTEN BY Fresh Gravity
Clinical trials are advancing, but outdated design processes continue to place a heavy, often unmeasured burden on patients. This whitepaper introduces a patient-centric, quantitative approach to modelling burden that can improve both ethics and efficiency in trials. Read more in the full whitepaper.
Stay updated with cutting-edge insights! Subscribe now and get our expert articles delivered straight to your inbox.
Written by Ramakanth Vanga, Manager, Data Management Key Takeaway Most enterprise AI spend is paying frontier-model prices to compensate for missing business context, not missing intelligence. Genie Ontology solves the context problem at the platform level, which means a much cheaper tier of models can start handling questions that used to require the most expensive […]
Written by Kedar Deshpande, Sr. Director, Clinical Data and Analytics Key Takeaway Despite billions invested in clinical technology, most clinical operations teams still run critical workflows on spreadsheets, email threads, and manual data entry. The cost of that inertia is measurable, compounding, and no longer acceptable. In this article Hide ▲ The Scale of Manual […]
Written by Kedar Deshpande, Sr. Director, Clinical Data and Analytics Studies on clinical development show that even a one-day delay in a clinical trial can have significant financial consequences, with Tufts CSDD estimating the direct daily cost of Phase II and Phase III trials at about $40,000 and overall revenue impact of $1 million. For […]
